Hap Trading, LLC Cor Medix Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	SELL	$4.46 - $7.11 $77,158 - $123,003	-17,300 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.05 - $10.09 $100,430 - $167,494	-16,600 Reduced 48.97%	17,300 $6,000
Q1 2021 May 14, 2021	BUY	$6.84 - $17.58 $106,020 - $272,490	15,500 Added 84.24%	33,900 $39,000
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $6,500 - $11,895	1,300 Added 7.6%	18,400 $17,000
Q3 2020 Nov 13, 2020	BUY	$3.96 - $6.15 $15,840 - $24,600	4,000 Added 30.53%	17,100 $13,000
Q2 2020 Aug 10, 2020	BUY	$3.08 - $6.56 $40,348 - $85,936	13,100 New	13,100 $23,000

109

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $502M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.